PBA
Paradigm Biocapital Advisors Portfolio holdings
AUM
$2.34B
This Quarter Return
+6.61%
1 Year Return
+13.3%
3 Year Return
+245.82%
5 Year Return
–
10 Year Return
–
AUM
$502M
AUM Growth
+$502M
(+33%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
25.49%
Top 10 Holdings %
Top 10 Hldgs %
77.67%
Holding
30
New
5
Increased
16
Reduced
1
Closed
7
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$37.7M |
| 2 |
argenx
ARGX
|
$33.7M |
| 3 |
Incyte
INCY
|
$24.4M |
| 4 |
United Therapeutics
UTHR
|
$20.6M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$17.6M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$15.3M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$15.1M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$14.3M |
| 4 |
Zentalis Pharmaceuticals
ZNTL
|
$13.3M |
| 5 |
Prothena Corp
PRTA
|
$9.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-907,428
| Closed | -$15.1M |
|
27
Fulcrum Therapeutics
FULC
$353M
| – | – |
-212,961
| Closed | -$5.04M |
|
|
ISEE
28
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-910,416
| Closed | -$15.3M |
|
|
29
Zentalis Pharmaceuticals
ZNTL
$123M
| – | – |
-287,577
| Closed | -$13.3M |
|
|
30
Prothena Corp
PRTA
$452M
| – | – |
-267,946
| Closed | -$9.8M |
|